Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GHSR | Q92847 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428132 | 0.99 | RIPK1 (0.36) | RIPK1PARP1HDAC3HDAC1HDAC2 | |
| SCHEMBL7705076 | 0.94 | HDAC1 (0.35) | RIPK1PARP1HDAC3HDAC1HDAC2 | |
| SCHEMBL6302929 | 0.91 | PARP1 (0.35) | PARP1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL6309909 | 0.91 | HSD17B10 (0.33) | PARP1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL6309617 | 0.91 | HDAC1 (0.43) | PARP1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL7704945 | 0.91 | HDAC3 (0.44) | PARP1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL7711139 | 0.90 | PARP1 (0.48) | RIPK1PARP1HDAC3HDAC1HDAC2 | |
| SCHEMBL6302723 | 0.89 | PARP1 (0.47) | RIPK1PARP1HDAC3HDAC1HDAC2 | |
| SCHEMBL7712797 | 0.89 | RIPK1 (0.36) | RIPK1PARP1HDAC3HDAC1HDAC2 | |
| SCHEMBL7704916 | 0.89 | HSD17B10 (0.35) | PARP1SMN1; SMN2HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6365736-B1 | TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |